U.S. Medical Equipment Stock News

In March 2026, FTI Consulting, Inc. appointed Kelly Henney as Senior Managing Director and Australia Leader of its Information Governance, Privacy & Security practice within the Technology segment, based in Sydney. Her background in artificial intelligence governance, data privacy, and digital risk, combined with legal and banking experience, enhances FTI’s ability to advise clients on complex regulatory and compliance challenges. Next, we’ll examine how Henney’s artificial intelligence...

In March 2026, Flex LNG Ltd. announced a new time charter for the Flex Aurora with a Supermajor, securing a firm two-year term plus optional extensions that could keep the vessel employed through 2034 and lift the company’s total contract backlog to a minimum of 55 years, or up to 82 years if all options are used. This incremental charter backlog adds further revenue visibility at a time when the company has flagged potential revisions to its full-year 2026 guidance amid volatile LNG...

Why Phreesia’s latest guidance cut matters for investors Phreesia (PHR) has drawn fresh attention after issuing lower fiscal 2027 revenue guidance, tying the reset to weaker spending from pharmaceutical clients. The announcement triggered a sharp share price drop and several analyst downgrades. See our latest analysis for Phreesia. The lowered fiscal 2027 revenue outlook, combined with mixed fourth quarter results and analyst downgrades, has sharply shifted sentiment. A 7 day share price...

In late March 2026, investors reacted to easing geopolitical tensions and a broader relief rally as confidence improved around NextNav’s prospects for an FCC Notice of Proposed Rulemaking tied to its 5G-based terrestrial GPS backup system. This shift in sentiment highlights how progress toward a clearer regulatory path can become a central driver of interest in NextNav’s spectrum-backed positioning and timing platform. Now we’ll examine how growing optimism around the FCC regulatory...

Oil driven pullback puts BKV in focus The recent easing of U.S. Iran tensions pushed oil prices lower, dragging energy names with them as traders locked in gains after a strong run and technical gauges flagged oversold conditions across the sector. BKV (BKV) was caught in that macro driven move, with selling pressure tied less to company specific headlines and more to shifting sentiment toward oil and gas exposure in the short term. See our latest analysis for BKV. That macro volatility sits...

On March 30, 2026, Option Care Health expanded its revolving credit facility by US$450 million to US$850 million and increased its share repurchase authorization to US$1 billion, while reaffirming its 2026 guidance. The move strengthens liquidity and signals management’s confidence in cash generation, giving the company more flexibility to fund growth and return capital to shareholders. We’ll now examine how the expanded US$1 billion buyback authorization reshapes Option Care Health’s...

Commvault Systems (CVLT) is back in focus after announcing a new alliance with NetApp to offer an integrated data protection and cyber resilience solution that leans heavily on AI driven ransomware detection and automated recovery. See our latest analysis for Commvault Systems. The recent AI centric alliances with NetApp and Microsoft Security come after a sharp 90 day share price return of negative 35.63% and a 1 year total shareholder return of negative 42.64%, even though the 3 year total...

For investors wondering whether Constellation Brands is starting to look like a value opportunity or is still pricing in a premium future, this article walks through key checks that can help you frame that question for yourself. The stock last closed at US$151.20, with a 7.1% return year to date. However, the 1 year return is a 10.8% loss, and the 3 and 5 year returns are 28.6% and 26.5% losses respectively. Recent coverage around Constellation Brands has focused on how investors are...

Qnity Electronics stock: what recent performance says about investor interest Qnity Electronics (Q) is drawing attention after a strong past 3 months, with the stock up about 37%. The latest close sits at US$116.53 and recent daily moves remain mixed. See our latest analysis for Qnity Electronics. The recent 37.1% three-month share price return suggests solid momentum building for Qnity Electronics, despite a one-day share price decline of 1.7% and only modest movement over the past month. If...

At the Citizens JMP Technology Conference 2026 held earlier this week, Grindr outlined a shift toward monetizing its existing largely non‑paying user base, detailing plans for AI-powered features, localized language tools for Brazil and Spain, and an eventual higher-tier “private jet” VIP subscription. An interesting takeaway is Grindr’s claim that AI-generated coding has already lifted engineer productivity by 1.5 times, hinting at potential efficiency gains alongside its planned premium...

Why Brookdale’s Latest Refinancing Matters for Stock Watchers Brookdale Senior Living (BKD) recently refinanced a chunk of its 2027 debt, securing US$185 million in new loans and repaying US$191 million in existing mortgages, pushing some maturities out to 2033. For investors, this refinancing touches two key areas: the timing of Brookdale’s future cash obligations and the terms under which its senior living communities are financed. See our latest analysis for Brookdale Senior Living. The...

Viper Energy stock overview Viper Energy (VNOM) has attracted attention after recent trading, with the share price closing at $46.47 and showing mixed short term returns, including a 2.36% move over the past day and 6.46% over the past month. See our latest analysis for Viper Energy. That 2.36% 1 day share price return comes after a 6.46% 30 day share price return and 19.83% year to date share price return. The 1 year total shareholder return sits at 30.36%, suggesting momentum has been...

Medline overview and recent share performance Medline (MDLN) has attracted fresh attention after recent trading, with the share price at $44.28 and short term returns of 0.6% over the past day, 7.1% over the past week and 0.5% over the past month. See our latest analysis for Medline. That short term momentum sits within a wider pattern, with a 90 day share price return of 9.0% and a matching year to date share price return of 9.0%. This suggests interest in Medline has been steadily...

If you are wondering whether Penguin Solutions is priced attractively right now, the recent share moves give you plenty to think about. The stock last closed at US$20.69, with returns of 24.0% over 7 days, 9.0% over 30 days, 2.0% year to date and 36.2% over 1 year, while the 5 year return sits at a 26.0% decline and the 3 year return at 25.5%. These mixed time frame returns mean recent news flow is important context for understanding what the market is reacting to. Investors looking at...

If you are wondering whether Fastly at US$33.50 is still a value opportunity or already pricing in a lot of optimism, this breakdown will help you frame what the current share price might be implying. The stock has moved sharply, with returns of 22.1% over the past week, 63.9% over the past month, 228.8% year to date and a very large gain over the past year based on its 549.2% return, set against a 5 year return of a 50.6% decline. Recent coverage has focused on Fastly's role in edge...

In March 2026, Leidos Holdings raised about US$1.39 billion through unsecured senior notes to help fund its planned acquisition of Entrust’s parent company and, days later, won a US$454.9 million U.S. Air Force contract to modernize the Cloud One platform with major commercial cloud partners. By pairing large-scale debt financing for a cybersecurity-focused acquisition with a multi-cloud Air Force modernization win, Leidos is reinforcing its role at the intersection of defense, cloud...

Dividend announcement puts Xenia Hotels & Resorts (XHR) payout under the spotlight Xenia Hotels & Resorts (XHR) has declared a quarterly cash dividend of US$0.14 per share, with a March 31, 2026 ex-dividend date. This has drawn attention to its payout ratio and dividend sustainability. See our latest analysis for Xenia Hotels & Resorts. The latest quarterly dividend lands at a time when the share price has climbed to US$14.81, with a 1-year total shareholder return of 57.17% and a 3-month...

Leadership shift in business owner segment AllianceBernstein Holding (AB) is in focus after its private wealth arm expanded Kim Mustin’s role to lead the Business Owner segment nationally, highlighting this client group as a key area of emphasis. See our latest analysis for AllianceBernstein Holding. That leadership shift comes as the stock trades at US$38.63, with a 7 day share price return of 8.33% and a 1 year total shareholder return of 16.12%, pointing to firm but measured momentum...

EACO (EACO) has just posted its Q2 2026 numbers, with recent quarterly revenue running between about US$93.9 million and US$122.5 million and basic EPS ranging from US$1.33 to US$1.95 over the last six reported quarters. Trailing twelve month revenue sits at US$445.0 million and EPS at US$7.13. Over that same trailing period, earnings grew 73.4% year over year and net profit margin reached 7.8% compared with 5.4% a year earlier, setting the backdrop for investors to evaluate how sustainable...

If you are wondering whether Edwards Lifesciences is attractively priced or not, the key is to separate the share price story from the underlying value story. The stock last closed at US$81.05, with returns of 2.2% over 7 days, a 3.4% decline over 30 days, a 5.0% decline year to date, but a 16.9% gain over the past year that may catch your eye. Recent coverage has focused on how Edwards Lifesciences fits into longer term themes in medical devices and investor sentiment toward the broader...

If you are wondering whether Williams Companies is priced attractively right now, it helps to start by looking at how the current market value lines up against the business fundamentals. The stock last closed at US$72.00, with a 7 day return of a 2.1% decline, a 30 day return of a 3.7% decline, and longer term returns of 18.3% year to date and 36.3% over the past year, with a very large 5 year gain of 286.5% adding important context. Recent price moves sit against ongoing interest in US...

If you are wondering whether O'Reilly Automotive is priced attractively right now, it helps to step back and look at what the recent share performance and valuation checks are really telling you. The stock last closed at US$91.42, with returns of 1.5% over 7 days, a 3.1% decline over 30 days, a 1.2% gain year to date, and a 1.3% decline over the past year, sitting against much stronger 3 year and 5 year returns of 59.2% and 165.4%. Recent attention on O'Reilly Automotive has focused on how...

Beam Therapeutics (BEAM) just cleared an important clinical hurdle, with Phase 1/2 BEACON trial results for its sickle cell therapy risto cel published in The New England Journal of Medicine. See our latest analysis for Beam Therapeutics. At a share price of US$24.66, Beam’s recent news around risto cel and BEAM-302 comes after a mixed stretch. A 1-day share price return of 1.82% and 7-day share price return of 11.13% contrast with a 90-day share price return of 9.14% and a 5-year total...

DLocal recently reported a sharp year-over-year drop in adjusted EBITDA and contracting gross margins, citing a renegotiated contract with a key customer and currency devaluations in emerging markets, and management signaled full-year results are likely to land at the lower end of prior guidance. This combination of weaker profitability and a more cautious outlook highlights how sensitive DLocal’s business is to individual client terms and macroeconomic volatility in its core markets. Next,...